Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EB-001 in Abdominoplasty Pain
NCT03429556Phase 2Terminated
- Sponsor
- Allergan
- Start
- May 2018
- Primary completion
- Jul 2018
- Modality
- Orthosteric Ligands, Bacterial Toxin Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of trenibotulinumtoxinE in postoperative pain, sponsored by Allergan. Started May 2018; status: terminated.
02
Drugs
trenibotulinumtoxinE
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03429556.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03429556.